(This is CNBC Pro’s live coverage of Monday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A tech giant and a consumer goods name were among the companies being talked about by analysts on Monday. Citi reiterated Dell Technologies as a buy, noting the stock could see strong gains after its upcoming inclusion into the S & P 500 index. Meanwhile, Morgan Stanley downgraded Church & Dwight to equal weight from overweight. Check out the latest calls and chatter below. All times ET. 6:27 a.m.: Proceed with ‘some caution’ into CrowdStrike investor day, Morgan Stanley says Morgan Stanley said it’s tactically cautious heading into CrowdStrike’s investor day next week. The cybersecurity stock has been closely watched since an update caused a global IT outage earliert his summer. While showing some concern, analyst Hamza Fodderwala kept his overweight rating and price target of $325, which implies upside of 31.9% over last week’s closing level. The blackout and its wake are likely to be a focus, he said. Yet Fodderwala said the company is “likely to regain customer trust and expect a largely positive reception from the > 5K attendees at the conference next week.” He also noted that annual recurring revenue forecasts remain high. But “better-than-feared” earnings results released last month “may not have been the clearing event we hoped for,” the analyst said. His note is partially titled “Proceeding with Some Caution.” “While expectations are low, we’d be cautious heading into Investor Day next week as forward estimates have yet to be fully reset for a consistent beat/raise trajectory from here,” Fodderwala said. “Longer term, we think the CRWD platform story remains intact and ARR should re-accelerate 2H of next year and into CY26.” CrowdStrike shares advanced 1.3% in Monday’s premarket. The stock is down 3.5% year to date. — Alex Harring 5:58 a.m.: JPMorgan says it’s neutral on GE HealthCare JPMorgan came out in Wall Street’s minority on GE HealthCare . Analyst Robbie Marcus initiated coverage at neutral, despite the majority of analysts polled by LSEG having a buy rating. Marcus’ $90 price target for December 2025 suggests 5.8% upside over Friday’s closing level. Marcus said the company is an “oligopoly player” within medical imaging and should be able to continue organic growth and operating on a healthy margin. Software options and pharmaceutical diagnostic agents can also help financials going forward, he said. But the “robust” multiple of 18x 2025 earnings has made him not “fully comfortable with the margin of safety nor have material confidence in the timing of a China rebound.” GE HealthCare shares have added around 10% in 2024. The company began trading early last year. — Alex Harring 5:51 a.m.: Morgan Stanley downgrades Church & Dwight After Church & Dwight’s runup, Morgan Stanley sees its bullish thesis having played out. Analyst Dara Mohsenian downgraded the consumer packaged goods stock to equal weight from overweight. Mohsenian’s $110 price target implies just 4.6% upside over Friday’s closing level. The analyst said the stock was fairly valued after ripping nearly 30% higher since the start of 2023. That makes it one of the best performers within the coverage area over that time period, Mohsenian said. Still, shares are up less than 12% in 2024, underperforming the S & P 500. CHD YTD mountain CHD year to date Mohsenian also said the overweight thesis that earned the stock an upgrade early last year is now basically worked through. On top of that, he noted a tough pricing environment for household and personal care stocks that can weigh on the Arm & Hammer parent. Looking ahead, he said there’s stronger plays within the sector. “From a company perspective, we are very forthright that there are no home runs in our coverage here from our vantage point,” he said. “We remain most bullish on OW rated Coca-Cola and Colgate as our top picks longer-term and see short-term upside at EW rated Clorox and Keurig Dr Pepper, despite our longer-term EW stances.” — Alex Harring 5:51 a.m.: Dell to rally on S & P 500 inclusion, Citi says Get ready for big gains in Dell Technologies shares, according to Citi. Analyst Asiya Merchant reiterated her buy rating and $160 price target on the stock — which implies upside of 57% from Friday’s close. Shares popped more than 6% in the premarket after S & P Dow Jones Indices announced late Friday that the laptop maker would rejoin the S & P 500 benchmark on Sept. 23. “Dell was a member of the S & P 500 from 1996 to 2013, before going private. In prior research we have identified the S & P 500 index inclusion as a potential catalyst,” Merchant wrote. “We believe DELL shares can continue to work post inclusion, given multiple other potential catalysts ahead including recovery in general purpose infrastructure demand, PC refresh cycle ahead into CY25, AI momentum and capital returns.” Year to date, shares have climbed more than 33%. DELL YTD mountain DELL year to date — Fred Imbert
EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel
